Skip to content

Clinical trials

Phase 2 Pancreatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Diseases Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20081
20093
20101
20111
20121
20161
20172
20182
20201
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated3
NanOlogy, LLC2
Agensys, Inc.1
Aimmune Nestlé Health Science US R&D, LLC1
Assistance Publique - Hôpitaux de Paris1
Astellas Pharma Inc1
Catalysis SL1
Merck Sharp & Dohme LLC1
Protalix1
Rezolute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Diseases17
Digestive System Diseases10
Pancreatic Neoplasms9
Digestive System Neoplasms6
Cystic Fibrosis5
Genetic Diseases, Inborn4
Lung Diseases4
Endocrine Gland Neoplasms3
Endocrine System Diseases3
Infant, Newborn, Diseases3

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.